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Abstract
Background: Mesenchymal stem cells (MSCs) have been widely applied to treat various inflammatory diseases.
Inflammatory cytokines can induce both apoptosis and autophagy in MSCs. However, whether autophagy plays a
pro- or con-apoptosis effect on MSCs in an inflammatory microenvironment has not been clarified.
Methods: We inhibited autophagy by constructing MSCs with lentivirus containing small hairpin RNA to
knockdown Beclin-1 and applied these MSCs to a model of sepsis to evaluate therapeutic effect of MSCs.
Results: Here we show that inhibition of autophagy in MSCs increases the survival rate of septic mice more
than control MSCs, and autophagy promotes apoptosis of MSCs during application to septic mice. Further study
demonstrated that autophagy aggravated tumor necrosis factor alpha plus interferon gamma-induced apoptosis of
MSCs. Mechanically, autophagy inhibits the expression of the pro-survival gene Bcl-2 via suppressing reactive
oxygen species/mitogen-activated protein kinase 1/3 pathway.
Conclusions: Our findings indicate that an inflammatory microenvironment-induced autophagy promotes
apoptosis of MSCs. Therefore, modulation of autophagy in MSCs would provide a novel approach to improve
MSC survival during immunotherapy.
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Background
Mesenchymal stem cells (MSCs) are a heterogeneous
population of multipotent stromal stem cells that can be
obtained from many tissues [1]. They not only possess
self-renew capability, but also they can differentiate into
a variety of mesodermal lineage cells, such as adipocytes,
osteocytes, chondrocytes, cadiomyocytes, and so forth
[2, 3]. In addition, MSCs play an important modulatory
role in both the innate and adaptive immune systems
through interaction with the inflammatory microenviron-
ment [4, 5]. Therefore, MSCs have engaged great interest
for clinical applications in treating various inflammatory
diseases, such as acute graft-versus-host disease [6], mul-
tiple sclerosis [7], rheumatoid arthritis [8], bone injury and
sepsis [9, 10]. However, there is little insight into the spe-
cific role of the inflammatory microenvironment on the
fate of MSCs.
The inflammatory microenvironment in vivo is crucial
for MSCs to mediate their immunoregulatory capability
[5, 11]. Inflammatory cytokines such as interferon (IFN)-γ,
tumor necrosis factor (TNF)-α, interleukin (IL)-1α and
IL-β, can activate MSCs to exert immunosuppressive
functions [3, 12]. Previous studies have shown that IL-
2-activated natural killer cells could efficiently lyse au-
tologous and allogeneic MSCs [13]. In addition, it has
been reported that IFN-γ synergistically enhances TNF-
α-induced MSC apoptosis, which inhibits the ability of
MSCs to mediate bone repair [9], suggesting that the
inflammatory microenvironment induced apoptosis of
MSCs in treating inflammatory diseases. Our previous
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study has demonstrated that inflammatory cytokines,
e.g., IFN-γ and TNF-α, induce autophagy in MSCs syn-
ergistically by inducing expression of Beclin 1, whereas
autophagy, in return, downregulates the immunosup-
pressive function of MSCs. Furthermore, inhibition of
autophagy by knockdown of Beclin 1 significantly im-
proves the therapeutic effects of MSCs on experimental
autoimmune encephalomyelitis (EAE) [14]. However,
whether inflammation-induced autophagy plays a role
in regulating MSC apoptosis remains elusive.
Sepsis is a serious medical condition, characterized by
a generalized inflammatory state caused by infection
[15]. As a model of sepsis, the process of cecal ligation
and puncture (CLP) closely resembles the human disease
[16, 17]. It has been reported that MSCs attenuate sepsis
via by acting on the monocytes, macrophages or neutro-
phils in the CLP mouse model [10, 18–20]. In this study,
we show that inhibition of autophagy in MSCs increases
the survival rate of septic mice more than control MSCs,
using the CLP model. This elevation is mainly due to
autophagy-aggravated TNF-α plus IFN-γ-induced apop-
tosis of MSCs. Our findings identify autophagy to be a
critical regulator of the apoptosis of MSCs during their
application for inflammatory diseases.
Materials and methods
MSC isolation and culture
Bone marrow MSCs were isolated as previously de-
scribed [14]. Briefly, bone marrow cells were flushed
out from the bone cavity of femurs and tibias of mice
with Dulbecco’s modified Eagle's medium low glucose
(L-DMEM, Hyclone, USA) containing 10 % fetal bovine
serum (FBS; Gibco, USA). A single-cell suspension of
all nucleated cells was obtained by passing all bone
marrow cells through a 70-μm cell strainer (BD Bio-
science, USA). All the single cells were seeded at 1 × 106
into 100-mm culture dishes (Corning, USA) and ini-
tially incubated for 48 hours at 37 °C and 5 % CO2.
To eliminate the nonadherent cells, the cultures were
washed with phosphate-buffered saline (PBS; Gibco)
twice on the second day. The attached cells were cul-
tured with L-DMEM supplemented with 15 % FBS,
2 mM L-glutamine (Invitrogen, USA), 100 U/ml peni-
cillin and 100 μg/ml streptomycin (Invitrogen). Cell
surface marker analysis confirmed that MSCs were
positive for CD44 and Sca-1, and negative for CD11b,
CD31, CD34, CD45, major histocompatibility complex
(MHC) class I and MHC class II (eBioscience, USA).
Lentiviral vector construction
Oligonucleotides with the following nucleotide sequences
were used for the cloning of small hairpin (sh)RNA-encod-





High-titer lentiviral stocks were produced and used at a
multiplicity of infection of 50 to infect MSCs and the effi-
ciency of infection exceeded 95 %. MSCs were stably in-
fected with negative control lentivirus (shNC-MSCs) or
lentivirus expressing shRNA inhibiting the essential au-
tophagy gene Beclin-1 (shBec1-MSCs).
Immunoblot
Cells were lysed with ice-cold RIPA containing protease
and phosphatase inhibitors (Roche, Switzerland). The ly-
sates were fractionated by SDS-PAGE and analyzed by
immunoblotting with specific antibodies to LC3 I/II,
GAPDH, Beclin 1, Bcl-2, and cleaved Caspase 3 (Cell
Signaling, USA).
CLP model induction and treatment
CLP was performed as previously described in C57BL/
6 J mice [10, 21]. Briefly, the mice were anesthetized and
the cecum was ligated by silk 4-0 and punctured twice
with a 21-gauge needle, squeezed gently to express a
small amount of fecal material and then returned to the
central abdominal cavity. In sham-operated mice, the
cecum was located but neither ligated nor punctured.
The abdominal incision was closed in two layers with
6-0 nylon sutures. After surgery, all mice received
antibiotic and fluid therapy subcutaneously. PBS,
shNC-MSCs or shBecn1-MSCs (1 × 106 cells/mouse)
were administered intravenously after the surgery.
Survival rate was assessed after surgery every 8 hours.
All aspects of the animal care and experimental pro-
cedures were in accordance with the Guide for the
Care and Use of Laboratory Animals and approved by
the Experimental Animal Care and Use Committee of
Nanjing Medical University.
Apoptosis in vivo
Apoptosis assay in vivo was performed as previously
described [9]. Briefly, shNC-MSCs and shBec1-MSCs
were suspended in PBS with 2 % FBS, mixed with
high concentration matrigel matrix (BD Biosciences),
and then injected on the back of naive and sepsis
mice subcutaneously for 24 hours. shNC-MSCs and
shBec1-MSCs were then isolated and stained with
annexin V/prodium iodide (PI) apoptosis detection kit
(Invitrogen) and measured by flow cytometry (BD
Aria, USA).
Apoptosis induction with TNF-α and IFN-γ
shNC-MSCs and shBec1-MSCs were stimulated with TNF-
α (20 ng/ml; R&D Systems, USA) plus IFN-γ (50 ng/ml;
R&D Systems) for 24 hours. In some experiments,
Dang et al. Stem Cell Research & Therapy  (2015) 6:247 Page 2 of 9
mitogen-activated protein kinase 1/3 (ERK) inhibitor
(PD98059; Merck, Germany) and reactive oxygen spe-
cies (ROS) inhibitor (N-acetyl cysteine (NAC); Sigma-
Aldrich) were added. In some other experiments, naive
MSCs were treated with 3-methyladenine (3-Ma;
10 mmol/L; Sigma-Aldrich) for 12 hours before stimu-
lation with TNF-α plus IFN-γ. Then cells were stained
with annexin V/PI and measured by flow cytometry.
Cytokine detection
The sera of naive and sepsis mice were quantified with
TNF-α, IFN-γ, IL-6 and IL-17 enzyme-linked immuno-
sorbent assay (ELISA) kit according to the manufac-
turer’s guidelines (R&D Systems).
Quantitative real-time polymerase chain reaction
Total RNA was extracted from MSCs at the indicated
times and was subsequently reverse-transcribed using a
Reverse Transcription System (Takara, Japan). Quantita-
tive polymerase chain reaction (PCR) was performed
using SYBR Green PCR mix (Roche) on an ABI Prism®
7900HT Sequence Detection System (Applied Biosys-
tems). β-actin was used as an internal control to
normalize for differences in the amount of total RNA in
each sample. The primer sequences are listed as follows
(in the 5 to 3 orientation): Bcl-2 forward GGGCATAGT
GAAGGCAGGAA, reverse TCCATAGACACGGGTCA
TCGA; Bcl-xl forward AGGTATTGGTGAGTCGGAT
TG, reverse TCTCGGCTGCTGCATTGTT; Bim forward
CTACATGCAGCCAGGATACGT; reverse ACACTGTC




SPSS 17.0 was used to perform the statistical analysis.
Significance was assessed using an independent two-
tailed Student’s t test or with analysis of variance.
We compared survival curves with a log-rank test
(Graphpad Prism 5.0). P < 0.05 was considered statis-
tically significant.
Results
Autophagy promotes apoptosis of MSCs under sepsis
state
It has been reported that inflammatory cytokines in
bone injury, mainly TNF-α and IFN-γ, are capable of in-
ducing MSC apoptosis [9]. Our previous study showed
that the inflammatory microenvironment could induce
autophagy of MSCs [14]. To investigate whether inflam-
matory cytokine-induced autophagy regulated apoptosis
of MSCs, we inhibited autophagy by constructed MSCs
with lentivirus containing shRNA to knockdown Beclin-
1, a key regulator of autophagy. As shown in Fig. 1a, the
expression of Beclin-1 was markedly decreased on im-
munoblots in shBec1-MSCs in parallel with reduced
level of LC3-II, indicating that knockdown of Beclin-1
was effective in suppressing autophagy. Then we
assessed survival rates of CLP mice treated with PBS,
shNC-MSCs or shBec1-MSCs. There was a significant
(P < 0.05) improvement in the survival of mice treated
with shBec1-MSCs compared to shNC-MSCs (Fig. 1b).
Next, to explore whether reduction of apoptosis played
a role in the elevated survival rate of shBec1-MSC-
treated mice, shNC-MSCs or shBec1-MSCs were
mixed with matrigel and injected subcutaneously into
naive and CLP mice. Our data demonstrated that the
percentage of apoptotic shBec1-MSCs and shNC-MSCs
were 28.5 ± 1.4 % and 38.0 ± 0.7 %, respectively (P < 0.01)
(Fig. 1c, d). These results suggest that autophagy enhances
apoptosis of MSCs in the inflammatory microenviron-
ment, which may result in reduction of the therapeutic ef-
fect of MSCs on CLP.
Autophagy promotes the apoptosis of MSCs induced by
inflammatory cytokines
To investigate how autophagy enhances apoptosis of
MSCs in the inflammatory microenvironment, we
assessed the inflammatory cytokines TNF-α, IFN-γ, IL-6
and IL-17 in CLP mice. Our data demonstrated that
there was a significant elevation of these cytokines in
CLP mice compared to naive mice (Fig. 2a). Then we in-
vestigated the expression of these inflammatory cyto-
kines after treatment with shBec1-MSCs/shNC-MSCs.
As shown in Fig. 2b, treatment with shBec1-MSCs/
shNC-MSCs significantly reduced the expression of
these inflammatory cytokines in CLP mice but not in
naive mice, and this effect was no different between
shBec1-MSCs and shNC-MSCs. Furthermore, we treated
shNC-MSCs or shBecn1-MSCs with TNF-α plus IFN-γ,
main cytokines that could induce apoptosis of MSCs, or
starvation conditions. Firstly, we found that inhibition of
autophagy promoted the apoptosis of MSCs under starva-
tion. Then we showed that treatment with TNF-α com-
bined with IFN-γ significantly induced apoptosis of MSCs,
whereas inhibition of autophagy suppressed apoptosis of
MSCs (shNC-MSCs 44.6 ± 1.7 % versus shBec1-MSCs
33.2 ± 1.5 %, P = 0.01) (Fig. 2c, d). These data suggest that
autophagy promotes survival of MSCs under starvation
but enhances apoptosis of MSCs under the inflammatory
microenvironment.
Autophagy promotes apoptosis of MSCs via
downregulation of Bcl-2
To explore the mechanisms of autophagy-regulated
MSC apoptosis, genes associated with apoptosis, e.g.,
Bim, Bcl-2, Bcl-xl, and Mcl-1, were examined with quan-
titative PCR. The results showed that TNF-α plus IFN-γ
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treatment inhibited the expression of the anti-apoptotic
gene Bcl-2, and inhibition of autophagy markedly in-
creased the constitutive mRNA levels of Bcl-2 (Fig. 3a),
suggesting that autophagy inhibited the expression of
Bcl-2. Studies have shown that Bcl-2 family proteins
regulate caspase activation-mediated apoptosis through
controlling the release of cytochrome c [22, 23]. Our
data demonstrated that autophagy inhibited the protein
levels of Bcl-2 and promoted TNF-α plus IFN-γ-induced
activation of caspase 3 (Fig. 3b), which enhanced TNF-α
plus IFN-γ-induced apoptosis of MSCs. To determine
whether a similar effect could be observed in the inflam-
matory environment in vivo, shNC-MSCs or shBec1-
MSCs were implanted on to the back of naive and sepsis
mice, and were then isolated for Bcl-2 and cleaved cas-
pase 3 expression. Our results show that the expression
of Bcl-2 was lower in CLP mice than in naive mice, and
inhibition of autophagy increased the expression of Bcl-
2 but decreased the expression of cleaved caspase 3
(Fig. 3c, d), results consistent with the data in vitro. We
had previously demonstrated that autophagy inhibited
the activation of the ROS/ERK pathway [14], and there
is abundant evidence that activation of the ERK pathway
can increase the expression of several pro-survival pro-
teins, notably Bcl-2, Bcl-xl and Mcl-1, in a variety of cell
types [23–25]. Therefore, we investigated activation of
the ROS/ERK pathway on the expression of Bcl-2 and
found that blocking activation of ERK inhibited the ex-
pression of Bcl-2 as well as inhibition of ROS (Fig. 3e).
To confirm this effect resulted from inhibition of au-
tophagy, but not from inhibition of Beclin 1, we applied
the autophagy inhibitor, 3-Ma, in this experiment, and
obtained the same results (Fig. 3f ). These data suggest
that autophagy inhibits the expression of Bcl-2 via sup-
pressing the ROS/ERK pathway.
Inhibition of the ROS/ERK pathway is responsible for
autophagy-mediated apoptosis of MSCs under
inflammatory conditions
To investigate whether the ROS/ERK pathway was in-
volved in autophagy-mediated apoptosis of MSCs, we
treated shNC-MSCs or shBecn1-MSCs with TNF-α plus
IFN-γ, and with ROS or ERK inhibitor. The data showed
that inhibiting ERK activation or ROS generation con-
siderably enhanced TNF-α plus IFN-γ-induced apoptosis
of shBec1-MSCs to a level similar to that of shNC-
MSCs (Fig. 4a). This result was also validated by inhib-
ition of autophagy with 3-Ma (Fig. 4b). Collectively,
these data suggest that autophagy promotes TNF-α plus
Fig. 1 Inhibition of autophagy improves survival of MSCs in CLP mice. a MSCs were stably infected with negative control lentiviral vector (shNC)
or with vector expressing shRNA to inhibit Beclin-1 (shBecn1); western blot analysis of shNC-MSCs and shBec1-MSCs. b Survival curves of CLP mice
treated with phosphate-buffered saline (PBS; n = 12 mice per group), shNC-MSCs (n = 14 mice per group) or shBec1-MSCs (n = 13 mice per group)
intravenously (1 × 106 cells/mouse). c, d shNC-MSCs or shBec1-MSCs were mixed with matrigel and were injected into naive and CLP mice
subcutaneously for 24 hours. c Then MSCs were isolated and stained with annexin V/prodium iodide (PI) for apoptosis assay. d Percentage
of MSC apoptosis after injection into naive (n = 4 mice per group) and CLP mice (n = 4 mice per group); data are shown as mean ± SEM.
*P < 0.05, **P < 0.01
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IFN-γ-induced apoptosis of MSCs through inhibiting the
ROS/ERK pathway-mediated anti-apoptotic function.
Discussion
Recently, MSCs have been found to be effective in treat-
ing inflammatory disease [4]. An inflammatory condition
that activates MSCs is critical for MSCs to perform im-
munoregulation [5]. Here we demonstrated for the first
time that autophagy enhanced apoptosis of MSCs under
septic conditions, whereas inhibition of autophagy in
MSCs increased the survival rate of septic mice. More-
over, we found that autophagy promoted TNF-α plus
IFN-γ-induced apoptosis of MSCs via inhibiting the ex-
pression of Bcl-2. This effect was due to autophagy sup-
pressing the ROS/ERK pathway (Fig. 5). Our findings
suggest that modulation of autophagy in MSCs may
present a novel strategy to improve MSC survival in sep-
sis and other inflammatory diseases.
Sepsis is a clinical syndrome occurring in patients fol-
lowing severe infection or injury, and is a leading cause
of morbidity and mortality worldwide [15]. Recent stud-
ies have demonstrated that MSCs can alleviate the
development of sepsis [20]; the effects include bacterial
clearance, suppression of inflammation, anti-apoptosis,
or stimulation of regenerative responses [18, 19, 26].
Németh et al. [10] report that MSCs attenuate sepsis
through secreting prostaglandin E2 (PGE2). Our previ-
ous study demonstrates that inflammatory cytokines
such as TNF-α and IFN-γ that are produced in EAE
induce autophagy of MSCs, whereas inhibition of au-
tophagy increases PGE2 production to augment the
immunoregulatory effect of MSCs on EAE [14]. In this
study, we found that inhibition of autophagy in MSCs
increased the survival rate of septic mice. In addition
to promoting MSC survival, this effect may be partially
associated with inhibition of autophagy in MSCs up-
regulating PGE2 secretion. Therefore, inhibition of au-
tophagy might be an optimal approach to improve the
therapeutic effect of MSCs.
Autophagy is an evolutionarily conserved catabolic
process by which cells deliver cytoplasmic components for
degradation into lysosomes [27]. Despite the considerable
advances in the biology of autophagy, our understanding
of the dual role of autophagy in cell survival and cell death
Fig. 2 Inhibition of autophagy moderately suppresses tumor necrosis factor alpha (TNF-α) plus interferon gamma (IFN-γ)-induced apoptosis of
MSCs. a Levels of cytokines in sera of naive mice (n = 8 mice per group) and cecal ligation and puncture (CLP) mice (n = 10 mice per group) were
determined by ELISA. Data are shown as mean ± SEM. b Naive or CLP mice were treated with phosphate-buffered saline (PBS; n = 6 mice per
group), shNC-MSCs (shNC; n = 6 mice per group) or shBec1-MSCs (shBecn1; n = 6 mice per group) intravenously (1 × 106 cells/mouse) for 8 hours
after the surgery. Levels of cytokines in sera of naive mice and CLP mice were determined by ELISA. Data are shown as mean ± SEM. c shNC-MSCs and
shBec1-MSCs were stimulated with TNF-α (20 ng/ml) plus IFN-γ (50 ng/ml) or starved with EBSS for 24 hours, and then the cells were harvested and
stained with annexin V/prodium iodide (PI). d Percentage of MSC apoptosis after treatment with TNF-α plus IFN-γ; data are shown as mean ± SEM of
five independent experiments. **P < 0.01. CTRL Control
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remains incomplete. It may play a pro-survival or pro-
death role in different physiological and pathological con-
ditions [28, 29]. Autophagy has been shown to protect
cells from death under conditions of starvation, growth
factor withdrawal and neurodegeneration, but is also a
critical contributing factor in certain types of cell death
[30, 31]. In this study, we found that autophagy promoted
TNF-α plus IFN-γ-induced apoptosis of MSCs, suggesting
that autophagy performed different functions under in-
flammation and starvation conditions. Thus, it is feasible
to modify autophagy in MSCs to achieve optimal thera-
peutic efficacy.
It is generally accepted that ROS induces autophagy,
and autophagy, in return, serves to reduce oxidative
products [32, 33]. ROS are small and highly reactive
molecules, including oxygen anions and free radicals,
which can oxidize proteins, lipids and DNA. When
tightly controlled, ROS participate in vital cellular signal-
ing by modulating the activity of the oxidized targets
[34]. They can directly or indirectly interact with critical
signaling molecules to initiate signaling in a broad
variety of cellular processes, such as nuclear factor kappa
B, MAP kinases, PI3 kinase and protein tyrosine phos-
phatases signal pathways [35]. Activation of these signal
pathways has also been shown to modulate gene expres-
sion, inflammatory responses and cell survival [36]. ROS
mediate cell death through caspase-dependent apoptosis
or necrosis when excessive ROS inactivate caspases
through oxidation [32]. ROS can also promote cell sur-
vival through activation of pro-survival transcription fac-
tors such as nuclear factor kappa B, ERK and heatshock
factors to increase expression of anti-apoptotic proteins
such as Bcl-2 and Bcl-xl [23, 37, 38]. In the previous
study, we found that generation of ROS was required for
activation of ERK, as inhibition of ROS generation sup-
pressed ERK activation resulting from inhibition of au-
tophagy and inflammatory stimuli [14]. In this study, we
demonstrated that autophagy suppressed the expression
of Bcl-2 through inhibition of ROS generation and ERK
activation. Blockade of ROS generation and ERK activa-
tion enhanced MSC apoptosis. Collectively, these data
indicate that inflammatory cytokine-induced autophagy
Fig. 3 Inhibition of autophagy promotes survival of MSCs via upregulation of Bcl-2. a shNC-MSCs (shNC) and shBec1-MSCs (shBecn1) were
stimulated with tumor necrosis factor alpha (TNF-α; 20 ng/ml) plus interferon gamma (IFN-γ; 50 ng/ml) for 4 hours. Expression of Bcl-2, Bcl-xl, Mcl-1
and Bim was then measured by quantitative real-time PCR. Data are shown as mean ± SEM of four independent experiments. b Western blot
analysis of shNC-MSCs and shBec1-MSCs stimulated with TNF-α (20 ng/ml) plus IFN-γ (50 ng/ml) for 6 hours. c, d shNC-MSCs or shBec1-MSCs
were mixed with matrigel and were injected into naive (n = 3 mice per group) and cecal ligation and puncture (CLP) mice (n = 3 mice per group)
subcutaneously for 24 hours. Expression of Bcl-2 was then measured by quantitative real-time PCR (c) and western blot (d). e shNC-MSCs and
shBec1-MSCs were stimulated with TNF-α (20 ng/ml) plus IFN-γ (50 ng/ml), or with PD98059 (20 μM) or N-acetyl cysteine (NAC; 10 mM) for
4 hours. Expression of Bcl-2 was then measured by quantitative real-time PCR. Data are shown as mean ± SEM of four independent experiments.
f MSCs were pretreated with 3-methyladenine (3-Ma) for 12 hours, and stimulated with TNF-α (20 ng/ml) and IFN-γ (50 ng/ml), or combined
with PD98059 (20 μM) or NAC (10 mM) for 4 hours. The expression of Bcl-2 was then measured by quantitative real-time PCR. Data are shown as
mean ± SEM of four independent experiments. *P < 0.05, **P < 0.01
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plays a pro-apoptotic role in MSCs and it does not bene-
fit the survival of MSCs in inflammatory conditions.
Therefore, inhibition of autophagy could be a possible
approach to improve the survival of MSCs when they
are transplanted for inflammatory diseases.
Conclusions
In summary, our findings indicate that inflammatory
condition-induced autophagy promotes apoptosis of
MSCs in sepsis. Therefore, modulation of autophagy in
MSCs may provide a novel approach to improve MSC-
Fig. 4 Inhibition of the ROS/ERK pathway is responsible for autophagy-mediated apoptosis of MSCs. a shNC-MSCs (shNC) and shBec1-MSCs
(shBecn1) stimulated with tumor necrosis factor alpha (TNF-α; 20 ng/ml) plus interferon gamma (IFN-γ; 50 ng/ml) or combined with PD98059 or
N-acetyl cysteine (NAC) before stimulation with TNF-α for 24 hours. b Naive MSCs were treated with 3-methyladenine (3-Ma; 10 mM) for 12 hours,
then stimulated with TNF-α (50 ng/ml) plus IFN-γ (50 ng/ml) or combined with PD98059 or NAC before TNF-α stimulation for 24 hours. Cells were
stained with annexin V/prodium iodide (PI) for apoptosis assay. Representative graphs from three independent experiments are shown
Fig. 5 The role of autophagy in inflammatory cytokine-induced apoptosis of MSCs. When MSCs were transplanted into the inflammatory
microenvironment of CLP mice, inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ), induced
apoptosis of MSCs by activating caspase 3. Meanwhile, these inflammatory cytokines induced autophagy of MSCs. Autophagy also inhibited the
expression of bcl-2 via suppression of the reactive oxygen species (ROS)/mitogen-activated protein kinase 1/3 (ERK) pathway, which promoted
the activation of caspase 3 and led to apoptosis of MSCs. On the contrary, inhibition of autophagy in MSCs activated the ROS/ERK pathway, which
reduced apoptosis of MSCs via upregulating Bcl-2 expression and inhibiting caspase 3 activation
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mediated therapy. And it will be valuable to investigate
whether inhibition of autophagy may improve the sur-
vival of MSCs in other inflammatory diseases such as
graft-versus-host disease and multiple sclerosis.
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